In Search of an HIV Vaccine: Meet the Researchers 'Standing On Each Others' Shoulders'

By In the early 1950s, when Jonas Salk produced the first inactivated polio vaccine and Albert Sabin later produced a live, attenuated, oral polio vaccine, the individual researchers' names were permanently linked to the products. But development of an HIV vaccine--a task President Bill Clinton has charged researchers to accomplish by 2007--requires the skills of so many scientists and so many laboratories worldwide that it would be impossible, and perhaps even improper, to link any vacci

Written byMyrna Watanabe
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

By

In the early 1950s, when Jonas Salk produced the first inactivated polio vaccine and Albert Sabin later produced a live, attenuated, oral polio vaccine, the individual researchers' names were permanently linked to the products. But development of an HIV vaccine--a task President Bill Clinton has charged researchers to accomplish by 2007--requires the skills of so many scientists and so many laboratories worldwide that it would be impossible, and perhaps even improper, to link any vaccine to one person's name.

"It's a pretty collaborative field these days; it's not as fractious as I heard it used to be," says Robert W. Doms , associate professor in the department of pathology and laboratory medicine at University of Pennsylvania in Philadelphia. Doms and others interviewed for this story describe the research community as very cooperative. "We are all standing on each others' shoulders and supporting each other," states Margaret Liu, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies